首页> 外文期刊>Case Reports in Infectious Diseases >Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
【24h】

Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient

机译:粪便微生物移植治疗持久性耐患者持续的多药抗性肺炎肺炎感染

获取原文
       

摘要

Dysbiosis of the microbiome is a common finding in critically ill patients, who receive broad-spectrum antibiotics and various forms of organ support. Multidrug-resistant (MDR) organisms are a growing threat in all areas of medicine, but most markedly in the critically ill, where there is both loss of host defences and widespread use of broad spectrum antibiotics. We present a case of a critically ill patient with persistent MDR Klebsiella pneumoniae infection, successfully treated with fecal microbiota transplantation (FMT), using stool of a rigorously-screened, healthy donor. FMT for Clostridium difficile colitis has been well described in the literature and is an established therapy for recurrent infections with Clostridium difficile. The use of FMT for other multidrug-resistant organisms is less frequently described, particularly in the context of critically ill patients. In our case, we have culture-documented clearance of the MDR Klebsiella pneumoniae form a patient of FMT.
机译:微生物组的消化性是危重病患者的常见发现,他接受广谱抗生素和各种形式的器官支持。多药物(MDR)生物是在所有医学领域的日益增长的威胁,但最明显的病情,既有宿主防御又丢失,广泛使用广谱抗生素。我们提出了一种具有持久性MDR Klebsiella肺炎感染的危重病人的案例,用粪便微生物群移植(FMT)成功处理,使用严格筛选的健康供体的粪便。对于梭菌性艰难梭菌性结肠炎的FMT在文献中已经很好地描述,并且是与梭菌性艰难梭菌的复发感染的既定疗法。使用FMT用于其他多药物的生物体不太频繁地描述,特别是在危重病患者的背景下。在我们的案例中,我们有文化记录的MDR Klebsiella肺炎的清除,形成了FMT的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号